Terns Pharmaceuticals Inc Sustainability Reports
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases. Its pipeline focuses on therapies for oncology, metabolic diseases, and obesity.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900S1ZDQMF4MYP709
FIGI: BBG00KK1SJ17
3 reports from 2020 to 2022